FDA will want to see more data from the AstraZeneca vaccine before approval: Dr. Gottlieb
Dr. Scott Gottlieb, former FDA commissioner, says the FDA will likely want to see more data from the AstraZeneca vaccine before it receives FDA approval. There are some advantages to the AstraZeneca vaccine in that it can be produced in large quantities and it doesn't need to be stored as carefully compared with the Pfizer and Moderna vaccines. He joins 'Closing Bell' to discuss.
Fri, Nov 27 202012:57 PM EST